151 related articles for article (PubMed ID: 32868539)
1. Fibrinolytic therapy in patients with COVID-19 and acute respiratory distress syndrome: Is this a feasible approach?
Savioli F; Rocha L; Góis A; Nakano LC
J Trauma Acute Care Surg; 2020 Dec; 89(6):e187-e188. PubMed ID: 32868539
[No Abstract] [Full Text] [Related]
2. Thrombolysis restores perfusion in COVID-19 hypoxia.
Arachchillage DJ; Stacey A; Akor F; Scotz M; Laffan M
Br J Haematol; 2020 Sep; 190(5):e270-e274. PubMed ID: 32735730
[No Abstract] [Full Text] [Related]
3. Fibrinolytic abnormalities in acute respiratory distress syndrome (ARDS) and versatility of thrombolytic drugs to treat COVID-19.
Whyte CS; Morrow GB; Mitchell JL; Chowdary P; Mutch NJ
J Thromb Haemost; 2020 Jul; 18(7):1548-1555. PubMed ID: 32329246
[TBL] [Abstract][Full Text] [Related]
4. Tissue plasminogen activator (tPA) treatment for COVID-19 associated acute respiratory distress syndrome (ARDS): A case series.
Wang J; Hajizadeh N; Moore EE; McIntyre RC; Moore PK; Veress LA; Yaffe MB; Moore HB; Barrett CD
J Thromb Haemost; 2020 Jul; 18(7):1752-1755. PubMed ID: 32267998
[TBL] [Abstract][Full Text] [Related]
5. Is there a role for tissue plasminogen activator as a novel treatment for refractory COVID-19 associated acute respiratory distress syndrome?
Moore HB; Barrett CD; Moore EE; McIntyre RC; Moore PK; Talmor DS; Moore FA; Yaffe MB
J Trauma Acute Care Surg; 2020 Jun; 88(6):713-714. PubMed ID: 32281766
[No Abstract] [Full Text] [Related]
6. Can spironolactone be used to prevent COVID-19-induced acute respiratory distress syndrome in patients with hypertension?
Cadegiani FA
Am J Physiol Endocrinol Metab; 2020 May; 318(5):E587-E588. PubMed ID: 32297520
[No Abstract] [Full Text] [Related]
7. Treating hypoxemic COVID-19 "ARDS" patients with almitrine: The earlier the better?
Bendjelid K; Giraud R; Von Düring S
Anaesth Crit Care Pain Med; 2020 Aug; 39(4):451-452. PubMed ID: 32653550
[No Abstract] [Full Text] [Related]
8. Salvage use of tissue plasminogen activator (tPA) in the setting of acute respiratory distress syndrome (ARDS) due to COVID-19 in the USA: a Markov decision analysis.
Choudhury R; Barrett CD; Moore HB; Moore EE; McIntyre RC; Moore PK; Talmor DS; Nydam TL; Yaffe MB
World J Emerg Surg; 2020 Apr; 15(1):29. PubMed ID: 32312290
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D Deficiency and ARDS after SARS-CoV-2 Infection.
Faul JL; Kerley CP; Love B; O'Neill E; Cody C; Tormey W; Hutchinson K; Cormican LJ; Burke CM
Ir Med J; 2020 May; 113(5):84. PubMed ID: 32603575
[No Abstract] [Full Text] [Related]
10. Could ruxolitinib be effective in patients with COVID-19 infection at risk of acute respiratory distress syndrome (ARDS)?
Caocci G; La Nasa G
Ann Hematol; 2020 Jul; 99(7):1675-1676. PubMed ID: 32405693
[No Abstract] [Full Text] [Related]
11. Considerations for Statin Therapy in Patients with COVID-19.
Dashti-Khavidaki S; Khalili H
Pharmacotherapy; 2020 May; 40(5):484-486. PubMed ID: 32267560
[No Abstract] [Full Text] [Related]
12. Efficacy and safety of corticosteroids in COVID-19 based on evidence for COVID-19, other coronavirus infections, influenza, community-acquired pneumonia and acute respiratory distress syndrome: a systematic review and meta-analysis.
Ye Z; Wang Y; Colunga-Lozano LE; Prasad M; Tangamornsuksan W; Rochwerg B; Yao L; Motaghi S; Couban RJ; Ghadimi M; Bala MM; Gomaa H; Fang F; Xiao Y; Guyatt GH
CMAJ; 2020 Jul; 192(27):E756-E767. PubMed ID: 32409522
[TBL] [Abstract][Full Text] [Related]
13. Viral Coagulopathy in Patients With COVID-19: Treatment and Care.
Kipshidze N; Dangas G; White CJ; Kipshidze N; Siddiqui F; Lattimer CR; Carter CA; Fareed J
Clin Appl Thromb Hemost; 2020; 26():1076029620936776. PubMed ID: 32687449
[TBL] [Abstract][Full Text] [Related]
14. Vitamin D receptor stimulation to reduce acute respiratory distress syndrome (ARDS) in patients with coronavirus SARS-CoV-2 infections: Revised Ms SBMB 2020_166.
Quesada-Gomez JM; Entrenas-Castillo M; Bouillon R
J Steroid Biochem Mol Biol; 2020 Sep; 202():105719. PubMed ID: 32535032
[TBL] [Abstract][Full Text] [Related]
15. Neuromuscular blocking agents (NMBA) for COVID-19 acute respiratory distress syndrome: a multicenter observational study.
Courcelle R; Gaudry S; Serck N; Blonz G; Lascarrou JB; Grimaldi D;
Crit Care; 2020 Jul; 24(1):446. PubMed ID: 32684169
[No Abstract] [Full Text] [Related]
16. Are statins safe in patients with COVID-19?
Karalis DG
J Clin Lipidol; 2020; 14(4):396-397. PubMed ID: 32682805
[No Abstract] [Full Text] [Related]
17. Raloxifene and Bazedoxifene Could Be Promising Candidates for Preventing the COVID-19 Related Cytokine Storm, ARDS and Mortality.
Smetana K; Rosel D; BrÁbek J
In Vivo; 2020; 34(5):3027-3028. PubMed ID: 32871847
[TBL] [Abstract][Full Text] [Related]
18. Catheter-Directed Thrombolysis in a Patient with Severe COVID-19 Pneumonia on Extracorporeal Membrane Oxygenation.
Padley GJ; Desai SS; Weaver C; Price LC; Arachchillage DJ; Ridge CA
Semin Thromb Hemost; 2020 Oct; 46(7):850-852. PubMed ID: 32886934
[No Abstract] [Full Text] [Related]
19. Risk of peripheral arterial thrombosis in COVID-19.
Mestres G; Puigmacià R; Blanco C; Yugueros X; Esturrica M; Riambau V
J Vasc Surg; 2020 Aug; 72(2):756-757. PubMed ID: 32417015
[No Abstract] [Full Text] [Related]
20. Immune-Mediated Coagulopathy in COVID-19 Infection.
Vadasz Z; Brenner B; Toubi E
Semin Thromb Hemost; 2020 Oct; 46(7):838-840. PubMed ID: 32877959
[No Abstract] [Full Text] [Related]
[Next] [New Search]
